[Breaking] Kolon TissueGene Plunges 13%... Volatility Interruption (VI) Repeatedly Triggered
Kolon TissueGene fell by double digits in early trading on the 20th, swinging sharply. Although the U.S. New York stock market closed higher overnight with all three major indexes rising, this proved insufficient to halt the aggressive selling in the individual domestic stock. ■ Early-Session Plung
![[Breaking] Kolon TissueGene Plunges 13%... Volatility Interruption (VI) Repeatedly Triggered](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F07%2F590479%2Fad744516e4f70f94%2Foriginal.webp&w=1920&q=75)
Kolon TissueGene fell by double digits in early trading on the 20th, swinging sharply. Although the U.S. New York stock market closed higher overnight with all three major indexes rising, this proved insufficient to halt the aggressive selling in the individual domestic stock.
■ Early-Session Plunge of 13%... VI Repeatedly Triggered
On the morning of the 20th, Kolon TissueGene was trading at 22,500 won, down 3,400 won (13.13%) from the previous trading day. As the decline widened rapidly from the start of the session, volatility interruptions (VI) were triggered in succession.
That morning, the static VI was first triggered at 24,300 won, with the static VI reference price set at 27,000 won. It was then triggered again at 21,600 won. VI is a market stabilization mechanism that temporarily applies single-price trading to ease price movements when a specific stock's price moves sharply in a short period. The repeated triggering of VI during the decline suggests that the stock's price volatility was considerable in early trading.
■ Individual Stock Plunge Unrelated to Wall Street Gains
The U.S. market, in contrast, closed higher overnight. On the 19th (local time), the Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite all rose around 0.2% in New York, helped by falling U.S. Treasury yields and recovering risk appetite. The U.S. Treasury's plan to expand buybacks of long-term government bonds eased some pressure on the bond market, lending support to equities.
Nevertheless, Kolon TissueGene's share price is under strong selling pressure, separate from the favorable U.S. market mood. While Wall Street's gains may boost sentiment in the domestic market, they cannot offset the supply and demand dynamics, catalysts, and short-term price burdens of an individual stock — a point evident in today's trading. In particular, stocks that have moved sharply in a short period can experience rapidly expanding volatility as profit-taking volumes collide with new buying.
■ Key Variables for the Share Price Ahead
Rather than interpreting the VI trigger itself as a signal of further decline or a rebound, more weight should be given to the fact that price volatility has expanded. Going forward, Kolon TissueGene's share price is expected to hinge on short-term factors such as where selling volume settles after the plunge, changes in trading volume, and whether an intraday low forms.
[This article was written with AI assistance. It is not intended to recommend or solicit investment in, or the purchase or sale of, any specific stock. Stock markets can exhibit high volatility depending on company-specific catalysts, supply and demand, and market conditions, so investment decisions and any resulting responsibility rest with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.



